Frontage Laboratories Announces Partnership with Quanterix and Validation of Simoa HD-1 Analyzer and Software to Support Biomarker Analysis
June 15, 2016
Frontage Laboratories, Inc., a Contract Research Organization based in Pennsylvania, New Jersey and China, announces that they are the first CRO to complete a GLP validation of the Simoa HD-1 Analyzer and software along with the interface to Watson LIMS.
May 24, 2016
Quanterix announces that the Company’s CEO and Executive Chairman, Kevin Hrusovsky, will be presenting at the 5th Annual One Mind Summit.
Quanterix Opens Call for Proposals for Second Annual Accelerator Grant Program Focused on Oncology and Liquid Tumor Biopsy Technology
April 18, 2016
Quanterix announces the recipient of its first annual Accelerator Grant Program and a call for proposals for its second grant, focused on oncology research. The state-of-the-art Simoa Accelerator Lab is a dedicated laboratory environment for custom assay development and clinical sample testing.
March 23, 2016
Quanterix announces it has secured $46 million in Series D funding from both new and existing investors. This infusion of capital will allow Quanterix to build on the significant growth realized in the last two years.
March 8, 2016
Quanterix announces that Kevin Hrusovsky, Executive Chairman and CEO, will present at the Cowen and Company 36th Annual Health Care Conference.
March 1, 2016
Quanterix announces that it has been selected by Fast Company as one of the world’s top 10 most innovative companies in 2016 in Sports – the only medical technology company to be recognized in this category.
Quanterix Names Frontage Laboratories as a Preferred Partner in Biomarker Assay Development and Testing Services in the Regulated Space
February 10, 2016
Quanterix announces an alliance with Frontage Laboratories, naming the Company as a Preferred Partner for assay research and development. Leveraging Simoa’s sensitivity and revolutionary digital approach for assay development and research, Frontage will have the ability to enter new markets and…
February 9, 2016
Quanterix announces that Analytical Chemistry, a leading peer-reviewed scientific journal, has published a truly groundbreaking new study authored by Dr. David Walt of Tufts University that prominently features Quanterix’s Single Molecule Array Detection technology, Simoa.
Quanterix Presented Ultrasensitive Technology at NFL Health and Safety Update & Interactive Head Health Showcase
February 5, 2016
Quanterix announces that is participating in the NFL Health and Safety Update & Interactive Head Health Showcase at Super Bowl 50.